• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH
Click for more information
0.00% 0.6¢

ALTERITY THERAPEUTICS LIMITED

Market Cap $31.47M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH
News: ATH Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical... 		21:30 0 80
21:30 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  80 
ATH
Ann: Ceasing to be a substantial holder 		20:43 8 1.1K
20:43 Last post  skint Comments Created with Sketch.  8  Views Created with Sketch.  1.1K 
ATH
New eye / PD related study by Finkelstein 		20:18 1 181
TRENDING NEWS

Access the latest Thematics Insights Report: What it takes to get a new drug to market in Australia

Read More   right-arrow Created with Sketch.
NEWS
08 May 2024
20:18 Last post  Scottsmyname Comments Created with Sketch.  1  Views Created with Sketch.  181 
ATH
Ann: Phase 2 DMC Recommends Continuing Clinical Trial as Planned 		11:56 4 750
11:56 Last post  grenade001 Comments Created with Sketch.  4  Views Created with Sketch.  750 
ATH
Biomarkers for AD predementia by Masters et al 		07/05/24 5 908
07/05/24 Last post  groins Comments Created with Sketch.  5  Views Created with Sketch.  908 
ATH
Hereditary hemochromatosis as potential target for ATH434 treatment 		05/05/24 1 495
05/05/24 Last post  Scottsmyname Comments Created with Sketch.  1  Views Created with Sketch.  495 
ATH
Ann: Change in substantial holding 		05/05/24 14 3.2K
05/05/24 Last post  Scottsmyname Comments Created with Sketch.  14  Views Created with Sketch.  3.2K 
ATH
Ann: Alterity Presents New Data on ATH434 		03/05/24 18 4.5K
03/05/24 Last post  Scottsmyname Comments Created with Sketch.  18  Views Created with Sketch.  4.5K 

See All Discussions arrow Created with Sketch.

Timeline

Phase 2 DMC Recommends Continuing Clinical Trial as Planned
08 May 08:27
 
Ceasing to be a substantial holder
08 May 08:20
 
Change in substantial holding
03 May 08:23
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 09:06
 
Application for quotation of securities - ATH
29 Apr 09:01
 
Alterity Presents New Data on ATH434
29 Apr 08:41
 
View More arrow Created with Sketch.

Featured News

AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
(20min delay)
Last
0.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $31.47M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $9.573K 1.633M

Buyers (Bids)

No. Vol. Price($)
70 66663606 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 12189391 9
View Market Depth
Last trade - 16.10pm 08/05/2024 (20 minute delay) ?
Last
0.6¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
0.6¢ 0.6¢ 0.6¢ 363313
Last updated 15.59pm 08/05/2024 ?
ATH (ASX) Chart

Top Stories

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Tamboran is listing on the NYSE, and Wall Street is paying attention If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne Larvotto Resources has discovered gold grading more than 65 grams per tonne at the Hillgrove project in NSW.
Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production Alara Resources has set itself up nicely in Oman to capitalise on an expected 75% surge in copper prices over the next two years.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.

Featured News

PMT Patriot sniffs pegmatite grades of 3.58% among the snows of Quebec
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
AWJ Auric sends off first gold to Perth Mint of 2024
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.